Roivant, Pfizer unveil Priovant Therapeutics focused on autoimmune disease treatments, Roivant stock surges

Shares of Roivant Sciences Ltd. ROIV, -2.30% shot up 10.0% in premarket trading Tuesday, after the biopharmaceutical company and drug giant Pfizer Inc. PFE, +0.56% unveiled Priovant Therapeutics, a bi...

Moderna Faces Challenges Beyond the Covid Vaccine. Its Stock Is Still a Buy for the Long Term.

In 2019, four pharmaceutical giants shared virtually all of the $33 billion worth of vaccine revenue earned worldwide. The pandemic has upended the vaccine business. Moderna has sold or contracted to ...